| Product Code: ETC7544310 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Generic Pharmaceuticals Contract Manufacturing Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 India Generic Pharmaceuticals Contract Manufacturing Market - Industry Life Cycle |
3.4 India Generic Pharmaceuticals Contract Manufacturing Market - Porter's Five Forces |
3.5 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Generic Pharmaceuticals Contract Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for affordable generic drugs globally |
4.2.2 Growing emphasis on outsourcing manufacturing to reduce costs and focus on core competencies |
4.2.3 Favorable government initiatives and policies supporting the pharmaceutical industry in India |
4.3 Market Restraints |
4.3.1 Regulatory challenges and compliance issues in the pharmaceutical sector |
4.3.2 Quality control and assurance concerns in contract manufacturing |
4.3.3 Intense competition from other countries offering contract manufacturing services |
5 India Generic Pharmaceuticals Contract Manufacturing Market Trends |
6 India Generic Pharmaceuticals Contract Manufacturing Market, By Types |
6.1 India Generic Pharmaceuticals Contract Manufacturing Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Branded Generics, 2021- 2031F |
6.1.4 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Unbranded Generics, 2021- 2031F |
6.2 India Generic Pharmaceuticals Contract Manufacturing Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By API, 2021- 2031F |
6.2.3 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Drug Product, 2021- 2031F |
6.3 India Generic Pharmaceuticals Contract Manufacturing Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.5 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Generic Pharmaceuticals Contract Manufacturing Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Oncology, 2021- 2031F |
6.4.3 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Immunology, 2021- 2031F |
6.4.4 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Antidiabetic, 2021- 2031F |
6.4.5 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Neurology, 2021- 2031F |
6.4.6 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.4.7 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.4.8 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Pain, 2021- 2031F |
6.4.9 India Generic Pharmaceuticals Contract Manufacturing Market Revenues & Volume, By Pain, 2021- 2031F |
7 India Generic Pharmaceuticals Contract Manufacturing Market Import-Export Trade Statistics |
7.1 India Generic Pharmaceuticals Contract Manufacturing Market Export to Major Countries |
7.2 India Generic Pharmaceuticals Contract Manufacturing Market Imports from Major Countries |
8 India Generic Pharmaceuticals Contract Manufacturing Market Key Performance Indicators |
8.1 Percentage increase in the number of new contract manufacturing partnerships |
8.2 Average turnaround time for manufacturing and delivery of pharmaceutical products |
8.3 Number of regulatory approvals obtained for contract manufacturing facilities |
8.4 Percentage of revenue invested in research and development for innovative manufacturing processes |
8.5 Rate of customer satisfaction and retention in contract manufacturing partnerships |
9 India Generic Pharmaceuticals Contract Manufacturing Market - Opportunity Assessment |
9.1 India Generic Pharmaceuticals Contract Manufacturing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 India Generic Pharmaceuticals Contract Manufacturing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 India Generic Pharmaceuticals Contract Manufacturing Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Generic Pharmaceuticals Contract Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Generic Pharmaceuticals Contract Manufacturing Market - Competitive Landscape |
10.1 India Generic Pharmaceuticals Contract Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 India Generic Pharmaceuticals Contract Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here